These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 20119669
1. Serological response to influenza vaccine after hematopoetic stem cell transplantation. Yalçin SS, Kondolot M, Albayrak N, Altaş AB, Karacan Y, Kuşkonmaz B, Aksu S, Cetin M, Göker H, Yurdakök K, Uçkan D. Ann Hematol; 2010 Sep; 89(9):913-8. PubMed ID: 20119669 [Abstract] [Full Text] [Related]
2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [Abstract] [Full Text] [Related]
4. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730 [Abstract] [Full Text] [Related]
5. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951 [Abstract] [Full Text] [Related]
6. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia. Souza AR, Braga JA, de Paiva TM, Loggetto SR, Azevedo RS, Weckx LY. Vaccine; 2010 Jan 22; 28(4):1117-20. PubMed ID: 20116631 [Abstract] [Full Text] [Related]
7. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, Dray L, Djian E, Strauss-Liviatan N, Grotto I, Wolf DG, Or R. Vaccine; 2011 Feb 17; 29(9):1777-82. PubMed ID: 21216315 [Abstract] [Full Text] [Related]
8. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. Jo YM, Song JY, Hwang IS, Lee J, Oh SC, Kim JS, Kim SR, Kim WJ, Cheong HJ. J Med Virol; 2009 Apr 17; 81(4):722-7. PubMed ID: 19235853 [Abstract] [Full Text] [Related]
9. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y. Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353 [Abstract] [Full Text] [Related]
10. Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage. Song JY, Ha SH, Kee SY, Jeong HW, Cheong HJ, Kim WJ. J Clin Virol; 2007 Feb 23; 38(2):149-52. PubMed ID: 17196876 [Abstract] [Full Text] [Related]
11. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W. Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661 [Abstract] [Full Text] [Related]
12. Immune response after influenza vaccination in children with cancer. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Pediatr Blood Cancer; 2005 Nov 19; 45(6):831-7. PubMed ID: 16007602 [Abstract] [Full Text] [Related]
13. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J. J Med Virol; 2007 Mar 19; 79(3):320-5. PubMed ID: 17245715 [Abstract] [Full Text] [Related]
14. [Safety of an influenza-split-vaccine in children]. Schmitt-Grohé S, Banzhoff A, Klaassen B, Zielen S. Klin Padiatr; 2001 Mar 19; 213(6):338-42. PubMed ID: 11713714 [Abstract] [Full Text] [Related]
15. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, Cho GJ, Hwang TG, Kim WJ. Vaccine; 2010 May 21; 28(23):3929-35. PubMed ID: 20394719 [Abstract] [Full Text] [Related]
16. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Vaccine; 2009 Jan 14; 27(3):454-9. PubMed ID: 19022318 [Abstract] [Full Text] [Related]
17. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City]. You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct 14; 25(5):351-4. PubMed ID: 22338222 [Abstract] [Full Text] [Related]
18. Low seroprotection against preseasonal influenza local strains in children might predict the upcoming epidemic influenza strains. Su WJ, Shao PL, Liu MT, Liu DP, Huang KC, Chang LY, Lu CY, Wang JR, Shih SR, Huang DT, Chi H, Huang LM. Clin Infect Dis; 2010 Jul 15; 51(2):171-6. PubMed ID: 20528478 [Abstract] [Full Text] [Related]
19. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? Skowronski DM, Tweed SA, De Serres G. J Infect Dis; 2008 Feb 15; 197(4):490-502. PubMed ID: 18275271 [Abstract] [Full Text] [Related]
20. Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003). Michiels B, Philips H, Coenen S, Denekens J, Van Royen P. Vaccine; 2006 Apr 12; 24(16):3145-52. PubMed ID: 16490288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]